2024 Corporate Advisory Council

APSF is pleased to recognize the following companies for their exceptional level of support of APSF

2024 Corporate Advisory Council

Platinum Level ($50,000)

Eagle PharmaceuticalsEagle Pharmaceuticals (eagleus.com)

Edwards LifesciencesEdwards Lifesciences (edwards.com) is a global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring.

Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.

Fresenius KabiFresenius Kabi (fresenius-kabi.us) is a global health care company that specializes in lifesaving medicines and technologies that are used to help care for critically and chronically ill patients, offering injectable medicine portfolios for anesthesia providers and a growing number of ready-to-administer products.

GE HealthcareGE Healthcare (gehealthcare.com) is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, that enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform.

Vertex PharmaceuticalsVertex Pharmaceuticals (vrtx.com). At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.

Gold Level ($30,000)

BDBD Blink Device Company
Blink Device Company

ICU Medical

Nihon Kohden America
Nihon Kohden America

Preferred Physicians Medical Risk Retention Group

Silver Level ($15,000)




Bronze Level ($10,000)




Special recognition and thank you to Medtronic for their support and funding of the APSF/Medtronic Patient Safety Research Grant ($150,000).


For more information about how your organization can support the APSF mission and participate in the 2023 Corporate Advisory Council, go to: apsf.org or contact Sara Moser at: [email protected].